Rockwell Medical, Inc. (RMTI) stock declined over -0.78% intraday to trade at $1.28 a share on NASDAQ. The stock opened with a loss of -3.03% at $1.3 and touched an intraday high of $1.33, falling -0.78% against the last close of $1.29. The stock went to a low of $1.26 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue61.93 Million
5Y Sales Change3.10%
Fiscal Year Ends2021-12-30
IndustryHealth Care Supplies
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Rockwell Medical, Inc. (NASDAQ: RMTI) stock price is $1.28 as of the last check on Friday, July 1. During the trading session, RMTI stock reached the peak price of $1.33 while $1.26 was the lowest point it dropped to.
The NASDAQ listed RMTI is part of Health Care Supplies industry that operates in the broader Health Care sector. Rockwell Medical, Inc. , together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally.
Dr. Raymond Dennis Pratt FACP, M.D.
Chief Devel. Officer
Dr. Russell H. Ellison M.D., M.Sc., MSc.
Pres, CEO & Director
Mr. Russell L. Skibsted M.B.A.
Exec. VP, CFO & Chief Bus. Officer
Mr. Michael DeYoung
VP of Operations
RMTI stock traded closed the last session at $1.28, which is $-0.01 or -0.78% lower than its previous close of $1.29. RMTI's current trading price is 2.40% lower than its 52-week high of $10.16 where as its distance from 52-week low of 1.25% is -87.40%.
Number of RMTI employees currently stands at -. RMTI operates from 30142 South Wixom road, Suite 501, Wixom, MI 48393, United States.
Official Webiste of $RMTI is: https://www.rockwellmed.com
RMTI stock volume for the day was 17,624 shares while in the previous session number of RMTI shares traded was 17,600 . The average number of RMTI shares traded daily for last 3 months was 66.19 Thousands.
The percentage change in RMTI stock occurred in the recent session was -0.78% while the dollar amount for the price change in RMTI stock was $-0.01.
In the recent session, the day high for RMTI stock was $1.33 while the low for RMTI stock touched on the day was $1.26.
The market value of RMTI currently stands at 11 Million with its latest stock price at $1.28 and 8.54 Million of its shares outstanding.